Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company is headquartered in Daly City, California. Show more

611 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CA, UNITED STATES, 94080, South San Francisco, CA, 94080, USA

https://sprucebio.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

143M

52 Wk Range

$7.00 - $240.00

Previous Close

$47.07

Open

$47.33

Volume

50,689

Day Range

$47.31 - $51.25

Enterprise Value

81.24M

Cash

96.3M

Avg Qtr Burn

-22.12M

Insider Ownership

3.52%

Institutional Own.

55.08%

Qtr Updated

06/30/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) Details Sanfilippo Syndrome Type B (MPS IIIB)	BLA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tildacerfont Details Polycystic ovary syndrome	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tildacerfont Details Major Depressive Disorder (MDD)	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tildacerfont Details Congenital adrenal hyperplasia, Primary biliary cholangitis, Liver disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tildacerfont Details Congenital adrenal hyperplasia	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.